HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

(5aR)-5a-C-pentyl-4-epi-isofagomine

structure in first source

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Imines: 310
  - Imino Sugars: 24
    - Imino Pyranoses
      - (5aR)-5a-C-pentyl-4-epi-isofagomine: 2
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - Imino Pyranoses
      - (5aR)-5a-C-pentyl-4-epi-isofagomine: 2
Carbohydrates: 22023
- Imino Sugars: 24
  - Imino Pyranoses
    - (5aR)-5a-C-pentyl-4-epi-isofagomine: 2

Experts

1.	Charollais-Thoenig, Julie: 2 articles (11/2018 - 01/2017)
2.	Demotz, Stéphane: 2 articles (11/2018 - 01/2017)
3.	Front, Sophie: 2 articles (11/2018 - 01/2017)
4.	Gallienne, Estelle: 2 articles (11/2018 - 01/2017)
5.	Martin, Olivier R: 2 articles (11/2018 - 01/2017)
6.	Almeida, Sofia: 1 article (11/2018)
7.	Marmy, Céline: 1 article (11/2018)
8.	Marti, Roger: 1 article (11/2018)
9.	Pilloud, Vincent: 1 article (11/2018)
10.	Wood, Tim: 1 article (11/2018)

Related Diseases

1.

Mucopolysaccharidosis IV (Morquio Syndrome)

01/27/2017 - "Altogether, these results indicated that (5aR)-5a-C-pentyl-4-epi-isofagomine constitutes a promising PC-based drug candidate for the treatment of GM1-gangliosidosis and Morquio disease type B."
11/01/2018 - "(5aR)-5a-C-pentyl-4-epi-isofagomine 1 is a powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B. "

Related Drugs and Biologics

1.	Galactosidases